Finn Albrechtsen
Direttore/Membro del Consiglio presso Q-LINEA AB
Profilo
Finn Sander Albrechtsen is currently a Director at Q-linea AB since 2023.
Prior to this, he held the position of Vice President-Research & Development at Dako Denmark ApS.
Posizioni attive di Finn Albrechtsen
| Società | Posizione | Inizio |
|---|---|---|
| Q-LINEA AB | Direttore/Membro del Consiglio | 13/06/2023 |
Precedenti posizioni note di Finn Albrechtsen
| Società | Posizione | Fine |
|---|---|---|
Dako Denmark ApS
 Dako Denmark ApS Medical SpecialtiesHealth Technology Dako Denmark A/S designs and manufactures cancer diagnostic systems. It produces reagents, antibodies, instruments, and software solutions to make diagnoses and determine treatments for patients suffering from cancer. The firm's product areas encompass Immunohistochemistry, pharmacoDiagnostics, molecular pathology, Hematoxylin and Eosin stain, special stains, flow Cytometry, and specific proteins. The company was founded by Niels Harboe in 1966 and is headquartered in Glostrup, Denmark. | Direttore Tecnico/Scientifico/R&S | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| Q-LINEA AB | Health Technology |
| Aziende private | 1 |
|---|---|
Dako Denmark ApS
Dako Denmark ApS Medical SpecialtiesHealth Technology Dako Denmark A/S designs and manufactures cancer diagnostic systems. It produces reagents, antibodies, instruments, and software solutions to make diagnoses and determine treatments for patients suffering from cancer. The firm's product areas encompass Immunohistochemistry, pharmacoDiagnostics, molecular pathology, Hematoxylin and Eosin stain, special stains, flow Cytometry, and specific proteins. The company was founded by Niels Harboe in 1966 and is headquartered in Glostrup, Denmark. | Health Technology |
- Borsa valori
- Insiders
- Finn Albrechtsen
